Patent · US Active

Materials and methods for cell-free expression of vaccine epitope concatemers

US11608363B2 · kind B2 · utility

0Cited by
5References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 1, 2019
Grant dateMar 21, 2023
Priority date
Expiry dateNov 2, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides materials and methods for cell-free expression of epitopes for immunotherapy applications. In particular, the present disclosure provides materials and methods for expressing concatenated epitopes using a cell-free protein synthesis platform for high throughput, large scale, and unbiased epitope screening and the generation of multi-epitope vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.